Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders

Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders

US Patent 9585932 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reversible stress-responsive material, preparation method, and use thereof2025
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses2024
Method for setting calibrated outflow water of quantitative outflow water faucet2024
High-viscosity, high-elasticity, and anti-aging composite modified asphalt and a2024
Method and system for detecting road intelligent compaction index2024
Customized water outlet setting method and customized water outlet method for qu2024
Human-enzyme mediated depletion of homocysteine for treating patients with hyper2024
Compositions comprising a variant polypeptide and uses thereof2024
Compositions comprising a variant Cas12i4 polypeptide and uses thereof2024
High-performance triple-crosslinked polymer and preparation method thereof2023
Methods for treating inflammatory disorders and traumatic brain injury using sta2023
Methods for treating inflammatory disorders and traumatic brain injury using sta2023